Effects of Body Mass Index on Hypertriglyceridemia Associated with Oral Bexarotene Therapy: A Post Hoc Analysis of an Open-Label Comparative Clinical Study of Combined Bexarotene and Phototherapy Versus Bexarotene Monotherapy for Japanese Patients with Cutaneous T-Cell Lymphoma

• Principais autores: Akimasa Sanagawa (Autor), Tomoaki Hayakawa (Autor), Aya Yamamoto (Autor), Yuji Hotta (Autor), Yoko Furukawa-Hibi (Autor), Akimichi Morita (Autor)
• Formato: Livro
• Publicado em: Adis, Springer Healthcare, 2024-06-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background Bexarotene, which has been approved for use in Japan since 2016, is an effective drug for cutaneous T-cell lymphoma; however, careful management is imperative because of its adverse events. We previously demonstrated the severity of bexarotene-associated hypertriglyceridemia and...